After six years of meticulous data collection and patient monitoring, DripDok is proud to announce a shift in our treatment protocols for NAD and NMN therapies. Our ongoing commitment to optimizing patient health has led us to conclude that the most effective and sustainable approach is through maintenance-level therapies — administered once or twice per month — rather than intensive 3, 5, 7, or 10-day protocols.
What Our Six-Year Data Shows #
Over the course of our extensive data collection — including hundreds of patients undergoing regular NAD and NMN IV infusions — we’ve observed striking patterns in epigenetic markers. On average, patients who followed a holistic lifestyle combined with monthly NAD or NMN IV treatments demonstrated an improvement in biological age by an average of 10 years.
Those who adhered to a comprehensive approach — combining regular infusions and healthy lifestyle practices — had their biological age significantly reduced according to epigenetic DNA testing.
Why Monthly Maintenance Outperforms Intensive Protocols #
- Sustained Benefit: Monthly infusions maintain elevated NAD+ levels consistently, preventing the “boom and bust” cycle
- Better Epigenetic Outcomes: Consistent therapy shows greater biological age reversal on DNA methylation testing
- Cost-Effective: Lower overall cost while achieving superior long-term results
- Lifestyle Integration: Easier to integrate into daily life, improving compliance
Protocol Change #
Effective immediately, DripDok is discontinuing 3, 5, 7, and 10-day NAD protocols. We are introducing monthly maintenance plans focused on long-term, sustainable health optimization.
Our patients who have already incorporated these lifestyle changes have shown dramatic improvements in their overall vitality, biological age, and health metrics.
